SYSTEMIC TREATMENTS AND OUTCOMES IN PEDIATRIC ATOPIC DERMATITIS (STOP AD)

PI(s): Joy Wan, MD, MSCE, Johns Hopkins University School of Medicine

Purpose: Can we develop and validate computable phenotypes for pediatric atopic dermatitis? How do systemic therapies for pediatric atopic dermatitis vary with respect to real-world effectiveness and safety?

Study Design: Data only observational

PaTH Partners:

• Johns Hopkins University
• Penn State University

Sponsor: NIH

Coordinating Center: Johns Hopkins University